Deerfield Management’s Acura Pharmaceuticals ACUR Stock Holding History

Deerfield Management’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,025,641	Closed	-$786K	–	118
2016 Q4	$786K	Hold	1,025,641	–	–	0.03%	102
2016 Q3	$1.64M	Hold	1,025,641	–	–	0.08%	81
2016 Q2	$1.9M	Hold	1,025,641	–	–	0.07%	88
2016 Q1	$2.9M	Hold	1,025,641	–	–	0.12%	84
2015 Q4	$2.56M	Hold	1,025,641	–	–	0.1%	96
2015 Q3	$2.41M	Buy	+1,025,641	New	+$3.49M	0.09%	111

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Deerfield Management's ACUR Position: Q1 2017 in Review

Deerfield Management sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 1,025,641 shares — an estimated $786K sold.

Deerfield Management first reported a position in ACUR in Q3 2015 and held it in 6 quarters. The position peaked at $2.9M in Q1 2016. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Deerfield Management reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Deerfield Management sold 1,025,641 Acura Pharmaceuticals shares in Q1 2017, an estimated $786K.
Deerfield Management first reported a position in Acura Pharmaceuticals in Q3 2015 and held it in 6 quarters.
Deerfield Management's Acura Pharmaceuticals position peaked at $2.9M in Q1 2016.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Deerfield Management's 13F filing for Q1 2017, filed 15 May 2017.